Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, President and Chief Executive Officer, and Darrel P. Cohen, M.D., Ph.D., Chief Medical Officer, are scheduled to participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 11:00 a.m. EDT.
圣地亚哥，2024年5月7日（GLOBE NEWSWIRE）——专注于治疗和预防影响全球患者的病毒相关癌症的临床阶段精准肿瘤学公司Viracta Therapeutics, Inc.（纳斯达克股票代码：VIRX）今天宣布，总裁兼首席执行官马克·罗瑟拉和首席医学官达雷尔·科恩医学博士，计划参加炉边活动美国东部时间2024年5月14日星期二上午11点，在加拿大皇家银行资本市场全球医疗保健会议上聊天。
A live webcast of the presentation will be available on the Investors section of the Viracta website under "Events and Webcasts" and archived for 90 days.
该演讲的网络直播将在Viracta网站的 “投资者” 部分的 “活动和网络直播” 下提供，并存档90天。
